. Number of QTL-GWAS pairs or triplets with evidence of co-localization Table) . 262 ( absolute = 0.27 -0.68), suggesting that the correlation signals are robust across treatments (Fig   263 3A) . In contrast, we observed potential treatment-specific effects on correlations between an 264 meCpG 241 bp upstream of IRF5 and expression of this gene on chromosome 7 (Fig 3B) , for 265 which correlation was observed in all conditions except after RV exposure ( = 0.11). In 266 contrast, correlation between DNA methylation levels one meCpG and SLC22A5 on 267 chromosome 5 were only observed after SA treatment (S3 Fig) .
GWAS eqtl-meQTL-GWAS eQTL-GWAS meQTL-GWAS
Taken together these data suggest that meCpGs in airway epithelial cells that co-localize 269 with asthma GWAS variants influence the expression of nearby genes, and that these effects can 270 be reduced or enhanced by microbial exposures. These observations suggest that environment-271 specific epigenetic responses at meCpGs contribute to asthma pathogenesis.
272
273 meCpGs at TSLP co-localize with an asthma risk variant 274 To more deeply characterize associations between an meQTL-GWAS pair and better understand 275 shared disease mechanisms between adult onset and childhood onset asthma, we focused on the 276 four meQTL-GWAS pairs that co-localized in both the adult onset and childhood onset asthma 277 GWASs (S3 Table) . These pairs all included an intergenic SNP (rs1837253) located 5.7 kb 278 upstream from the TSS of the TSLP gene on 5q22, encoding an epithelial cell cytokine that plays 279 a key role in the inflammatory response in asthma and other allergic diseases [28] . rs1837253 co-280 localized with four meCpGs (cg15557878, cg10931190, cg15089387, cg25328184) in both the 281 adult onset (p GWAS = 2.77x10 -13 ) and childhood onset (p GWAS = 2.33x10 -27 ) asthma GWASs. The 282 four meCpGs are located in the first (untranslated) exon (5' UTR) of the TSLP gene (Fig 4) , a 283 region characterized as a promoter in keratinocyte primary cells (NHEK; ROADMAP). In fact, 284 rs1837253 was the lead SNP within previous asthma GWASs (e.g. [12, 29] ). The rs1837253-C 285 asthma risk allele is associated with decreased methylation at each of the four meCpGs (Fig 4) .
286 Because the meQTL for each of the four meCpGs were observed in each treatment condition, we 287 suggest that the first untranslated exon of TSLP is epigenetically poised for genotype-specific 288 expression in epithelial cells.
289
Although this is the first study to annotate the asthma-associated rs1837253 as an 290 meQTL, previous studies have shown TSLP to be a methylation-sensitive gene and that 291 hypomethylation at its promoter is associated with atopic dermatitis (AD) and prenatal tobacco 292 smoke exposure [30, 31] . Another study showed that increased excretion of TSLP in primary 293 cultured nasal epithelial cells after exposure to polyI:C (a dsRNA surrogate used to simulate viral 294 infection) was associated with the CC genotype [32]. Our co-localization studies further suggest 295 that the C allele is associated both with hypomethylation at CpG sites in an untranslated exon of 296 TSLP, and with adult onset and childhood onset asthma. Furthermore, the lack of LD of SNPs 297 with rs1837253 (± 50 kb) in European (r 2 < 0.12) and African American (r 2 < 0.12) 298 1000Genomes reference panels suggests that this SNP may indeed be causal for variation in 299 DNA methylation levels at TSLP and its association with asthma. 
328
We also detected four meQTL-GWAS pairs among the six co-localizations at 17q that 329 were associated with three meCpGs (cg24910161, cg21230266, cg17401724) and four SNPs at 330 the distal end of (rs3902025, rs4239225, rs3859191) and beyond (rs66826786) the extended 17q
331 haplotype where there is a breakdown of LD with SNPs in the core region. Two of these CpGs 332 were each located 27 bp upstream (cg24910161) and in an intron (cg21230266) of GSDMA in 333 regions characterized by ROADMAP as enhancers in NHEK cells. SNPs in modest to perfect 334 LD (r 2 range =0.46 -1.00; 1000 Genomes European panel) with these co-localizations (rs3902025, 335 rs4239225, rs3859191) were described in previous studies as independent GWAS signals for 336 asthma (rs3894194) or as an eQTL for GSDMA (rs3859192) [4, 38, 39]. The meQTL-GWAS co-337 localization associated with cg24910161 was specific to the SAveh treatment, while those 338 associated with cg21230266 were present in three conditions (RV, SA, and SAveh).
339
The one eQTL-meQTL-GWAS triplet in this region was associated with expression of 340 ERBB2 (Fig 5B) , more than 361 Kb proximal to the co-localized asthma risk variant in an intron 341 of MED2 (rs66826786) and to the co-localized meCpG (cg17401724), distal to rs66826786 and 
371
Using MR, we detected a causal relationship between methylation and gene expression 372 for each of the 14 triplets, indicating that DNA methylation at the meCpG mediates the genotype 373 effects (eQTL) on gene expression (FDR < 0.10; Table 3 ). Specifically, for 12 of the triplets, we 374 detected a causal relationship between methylation and gene expression in all four treatment 375 conditions. These triplets were associated with four genes (ACO2, GSTO2, IRF5, PMM1) and 376 nine meCpGs. For one triplet, the association with FRK was significant in the SA and SAveh 377 treatments only, suggesting the methylation effects on this gene is specific to the culture 378 conditions used for the SA experiment (SA+SAveh). For the remaining triplet, meCpG effects on 379 ERBB2 gene expression was only detected in RV-treated cells (FDR < 0.02, lfsr RV = 1.6x10 -4 ), 380 suggesting a long-range interaction after exposure to RV, as discussed above. ACO2 cg10386501 rs5758461 22:42162189 7.00E-02 0.00E+00 0.00E+00 7.00E-03 7.69E-02 0.00E+00 0.00E+00 1.03E-02 GSTO2 cg23659134 rs156697 10:106039185 2.50E-02 3.00E-03 0.00E+00 0.00E+00 3.04E-02 5.25E-03 0.00E+00 0.00E+00 GSTO2 cg07488549 rs276210 10:106046403 1.30E-02 0.00E+00 0.00E+00 0.00E+00 1.69E-02 0.00E+00 0.00E+00 0.00E+00 IRF5 cg26616347 rs3778754 7:128575552 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 PMM1 cg04809988 rs12483998 22:41935362 6.00E-03 4.20E-02 1.00E-03 0.00E+00 9.33E-03 4.70E-02 2.07E-03 0.00E+00 PMM1 cg02738086 rs9607812 22:41941243 5.00E-03 3.80E-02 1.00E-03 0.00E+00 8.00E-03 4.34E-02 2.07E-03 0.00E+00 PMM1 cg07830128 rs4822038 22:41958495 1.10E-02 1.00E-02 1.00E-03 0.00E+00 1.50E-02 1.40E-02 2.07E-03 0.00E+00 PMM1 cg07830128 rs9607819 22:41958862 7.00E-03 4.00E-03 0.00E+00 1.00E-03 1.03E-02 6.59E-03 0.00E+00 2.07E-03 PMM1 cg12016267 rs715498 22:42148467 1.30E-02 2.00E-03 0.00E+00 0.00E+00 1.69E-02 3.61E-03 0.00E+00 0.00E+00 All Conditions PMM1 cg10386501 rs5758461 22:42162189 2.90E-02 1.50E-02 9.00E-03 0.00E+00 3.38E-02 1.91E-02 1.29E-02 0.00E+00 Treatment (microbe)-specific ERBB2 cg17401724 rs66826786 17:38206092 0.00E+00 8.05E-01 1.44E-01 2.36E-01 0.00E+00 8.05E-01 1.52E-01 2.45E-01
Culture condition-specific FRK cg20254830 rs10456902 6:116333742 8.04E-01 1.43E-01 0.00E+00 2.40E-02 8.05E-01 1.52E-01 0.00E+00 2.99E-02
Overall, the MR results provide additional, orthogonal evidence for co-localized triplets 384 and novel evidence for causal inference with respect to the co-localized traits (DNA methylation, 385 gene expression). These results reinforce arguments for epigenetic mechanisms of disease that 386 occur not only independent of exposures but also for epigenetic mechanisms that modify gene 387 expression in response to environmental exposures.
388
389 Discussion 390 One of the major challenges of genetic research is to uncover molecular mechanisms of disease 391 and to understand how genetic and environmental factors interact to influence these mechanisms 392 and individuals' risk for disease. Genome-wide association studies have identified thousands of 393 SNPs associated with complex diseases; however, the functions of non-coding SNPs identified in 394 GWASs, and therefore the molecular mechanisms in which they result in disease, is difficult to 395 infer from GWAS alone. Furthermore, other important contributors to disease pathophysiology 396 are not readily informed by GWAS, including epigenetic, environmental, and tissue-or cell type-397 specific effects. Cell models address these limitations and advance our understanding of disease 398 pathobiology through experimental testing of disease mechanisms in controlled environments. In 399 this multi-omics study, we leveraged an airway epithelial cell model of microbial response to 400 identify functional variants that may have context-specific effects on transcriptional and 401 epigenetic responses and participate in molecular mechanisms that lead to a disease with an 402 underlying airway epithelial etiology. SNPs that were molecular QTLs in these models were co-403 localized with adult onset and childhood onset asthma GWAS SNPs to identify 72 unique co-404 localizations in at least one treatment condition. Integrating this information using Mendelian 405 randomization provided inferences into causality and insight into the molecular basis of 406 childhood onset asthma.
407
It is notable that we identified only six co-localizations with adult onset asthma GWAS 408 SNPs, compared to 70 with childhood onset asthma GWAS SNPs. None of the colocalizations in 409 the adult onset GWAS included an eQTL compared to 39 childhood onset co-localizations with 410 eQTLs, and only four meQTL-GWAS pairs were shared between adult and childhood onset 411 asthma, despite the fact the participants in our cell culture studies were all adults. Moreover, 412 even though there were 2.5-times the number of loci associated with childhood onset asthma 413 compared to adult onset asthma in the GWASs [12], we identified more than 11-times more co-414 localizations using the childhood onset compared to the adult onset GWAS results (70 vs. 6, 415 respectively). These observations likely reflect the more important role of gene regulation and 416 dysregulation in airway epithelium in the etiology of childhood onset asthma compared to adult 417 onset asthma [41] . Focusing on other tissues (e.g., lung tissue) or cell types (e.g., immune cells)
418 might yield more co-localizations with adult onset GWAS SNPs or more shared co-localizations 419 between adult onset and childhood onset asthma.
420
Our study provides mechanistic evidence for associations between GWAS SNPs and 421 asthma at two important asthma loci: the TSLP locus at 5q22.1 and the 17q12-21 locus. Co-422 localizations of the asthma associated SNP rs1837253 with DNA methylation levels in the TSLP 423 gene suggest an epigenetic mechanism of disease that contributes to both adult and childhood 424 onset asthma. Associations of this SNP with asthma have been highly replicated in GWASs and 425 TSLP is recognized as an important regulator in asthma pathogenesis through its broad effects on 426 innate and adaptive immune cells promoting Th2 inflammation [42] . Our data further show that 427 the effect of rs1837253 genotype on risk for both adult and childhood onset asthma is mediated 428 through DNA methylation levels at CpG sites in the untranslated first exon of the TSLP gene in 429 airway epithelial cells. Finally, the lack of LD with other SNPs in a 100 kb window suggests that 430 rs1837253 may indeed be the causal asthma SNP at this important locus.
431
Mendelian randomization of the childhood onset asthma 17q locus eQTL-meQTL-432 GWAS triplets revealed a novel epigenetic mechanism through which a SNP at the17q locus was 433 associated with expression of ERBB2 only after exposure to RV. This eQTL was mediated 434 through differential methylation that was present in all treatment conditions. Previous studies 435 have shown that variation at the 17q core locus confers risk to asthma only among children who 436 experience wheezing illness in early life [36, 37] , particularly with RV-associated wheezing [35] .
437 Our study further connects RV infection and genotype at this locus but implicates for the first 438 time interaction effects between genetic and methylation variation at the distal end of the locus 439 and the expression of ERBB2 at the proximal end of the locus only in RV infected epithelial 440 cells. The SNP that is the eQTL for ERBB2 in RV infected epithelial cells was also associated 441 with asthma in the childhood onset asthma GWAS (p GWAS = 6.43x10 -26 ), directly connecting the 442 eQTL for ERBB2 in RV-treated cells to asthma risk. The asthma associated allele, rs66826786-443 C, which was associated with decreased expression of ERBB2 in our study (Fig 5B) , is consistent 444 with results of a study of 155 asthma cases and controls that reported an inverse correlation 445 between ERBB2 expression in ex vivo lower airway epithelial cells and asthma severity [43] .
446 These combined data suggest that the low expression of ERBB2 associated with asthma severity 447 may be modulated by RV, the most common trigger of asthma exacerbations, via epigenetic 448 mechanisms involving DNA methylation and long-range chromatin looping between the 449 proximal and distal ends of this important locus. Our findings further highlight the importance of
